HSG acquires approximately 80% of PeierTech, with existing management retaining an ownership stake and continuing to lead operations

JIANGYIN, China, Oct. 29, 2026 /PRNewswire/ -- PeierTech, a manufacturer of medical-grade nitinol materials and precision components, today announced that HSG completed its acquisition of a controlling stake in the company.

Following the transaction, HSG holds approximately 80% of PeierTech, while the existing management team retains the remaining equity and will continue to oversee day-to-day operations. HSG also plans to introduce a market-based equity incentive program for key members of management to support the company's continued growth and international expansion.

Founded in 2002 and headquartered in Jiangyin, Jiangsu Province, PeierTech supplies medical device manufacturers worldwide with nitinol (nickel-titanium alloy) materials, precision components, and assembly services. Its integrated manufacturing capabilities support customers throughout product development, validation, and commercial-scale production across a range of medical applications, including cardiovascular, neurovascular, peripheral vascular, gastrointestinal, urological, dental, orthopedic, sports medicine, and other medical applications.

Amy Shen, CEO of PeierTech, said: "Our vision has always been to become a trusted strategic partner to medical device innovators worldwide. HSG's investment marks a new chapter for PeierTech, bringing financial support, international experience, and an extensive industry network that will help us pursue our next phase of growth. We remain committed to putting our customers first and delivering the quality, reliability, and technical support they expect from us."

Steve Jia, Partner at HSG, said: "PeierTech has established a leading global position in a highly specialized segment of medical device manufacturing, built on deep technical expertise and longstanding customer relationships. We see significant opportunities to further strengthen its global position through international expansion, operational improvements, and market consolidation. We look forward to working closely with Amy and her team to pursue those opportunities and create lasting value."

About PeierTech

PeierTech is a manufacturer specializing in medical-grade nitinol materials, precision components, and contract manufacturing solutions. Founded in 2002 and headquartered in Jiangyin, Jiangsu Province, the company serves medical device manufacturers in 20+ countries, offering integrated solutions covering nitinol wire and tubing, precision processing, and device assembly. Its manufacturing capabilities include laser cutting and welding, heat treatment, surface finishing, braiding, grinding, stamping, riveting, coating, and precision assembly. PeierTech's products and services support a range of medical applications, including cardiovascular, neurovascular, peripheral vascular, gastrointestinal, urological, dental, orthopedic, sports medicine and other medical applications. Visit www.peiertech.com.

About HSG

HSG, formerly known as Sequoia China, is a leading venture capital and private equity firm investing globally across the technology, healthcare, and consumer sectors. With offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, HSG manages over USD 61 billion in assets for institutional investors worldwide, as of June 30, 2026. Since its founding in 2005, HSG has backed more than 1,800 companies led by entrepreneurs building transformative technologies and category-defining businesses. To date, over 190 HSG portfolio companies have gone public, and over 140 have reached unicorn status. For more information, visit www.hsgcap.com.

View original content:https://www.prnewswire.com/news-releases/peiertech-announces-completion-of-majority-investment-by-hsg-302924096.html

SOURCE PeierTech